Vol 7, No 3 - PHA Online University

More documents

Recommendations

Info

Building Medical Education in PH: A Partnership Initiative to Advance Medical Understanding of Pulmonary Hypertension Building Medical Education in PH events are designed to foster partnerships between PHA and PH Centers to promote continuing education in the field of Pulmonary Hypertension through CME educational events. Upcoming Events for Medical Professionals Include: February 13, 2009 Warrensville Heights, OH PAH in the Real World: Managing the Aspects of a Frequently Missed Diagnosis Symposium University Hospitals Case Medical Center Pulmonary Arterial Hypertension is a frequently misunderstood diagnosis. This one-day symposium will offer lectures, case studies and open discussions with key opinion leaders in the area of pulmonary hypertension. After attending this symposium, one should better understand this unusual disease process. Visit http://cme.case.edu or call 216-983-1239. March 13 – 14, 2009 San Francisco, CA 2nd International Conference on Neonatal and Childhood Pulmonary Vascular Disease University of California, San Francisco It is increasingly clear that pulmonary vascular pathology is integral to a number of childhood disorders. In this symposium, we will bring together international experts to explore our current understanding of the basic pathobiology as well as new and future therapies for neonatal, pediatric and adult pulmonary vascular disease. Visit https://www.cme.ucsf.edu/cme/ or call 415-476-4251. June 4, 2009 Hartford, CT 3rd Annual Pulmonary Hypertension Symposium Yale University School of Medicine This one-day symposium will provide current educational information to properly diagnosis and treat pulmonary hypertension. More information will be available in 2009. To view the agenda from Yale’s 2nd Annual PH Symposium visit http://cme.yale.edu/conferences/. To partner with PHA in Building Medical Education in PH for your upcoming CME event, please contact Jennie Carman, Meetings Planning Associate, at 301-565-3004 x763 or BME@PHAssociation.org.
SECOND WIND IN PAH
Page 1 and 2: Advances in Pulmonary Hypertension
Page 3 and 4: Editorial Advisory Board Editor-in-
Page 5: Advances in Pulmonary Hypertension
Page 10 and 11: FLOLAN ® (epoprostenol sodium) for
Page 12 and 13: REMODULIN ® (treprostinil sodium)
Page 14 and 15: Advances in Pulmonary Hypertension
Page 16 and 17: Continuing Medical Education Sectio
Page 18 and 19: mal metabolism, some electrons leak
Page 20 and 21: 64. Gilde AJ, van der Lee KA, Wille
Page 22 and 23: Survival probablility (%) 13 12 11
Page 24 and 25: velopment may reveal novel targets
Page 26 and 27: lent correlation between impedance
Page 28 and 29: a Figure. (a) Schematic showing the
Page 30 and 31: Continuing Medical Education Sectio
Page 32 and 33: Conclusion Although it is not clear
Page 34 and 35: Connective Tissue Disease-Associate
Page 36 and 37: ACCP Update and New Treatments for
Page 38 and 39: the real cause of most morbidity an
Page 40 and 41: In the treatment of pulmonary arter
Page 42 and 43: LETAIRIS® (ambrisentan) 5 mg and 1
Page 44 and 45: Reference: 1. Badesch DB, Abman SH,
Page 46 and 47: Use of TRACLEER ® requires attenti
Page 48: Program Announcement: New Applicati

Vol 7, No 3 - PHA Online University

Create successful ePaper yourself

Delete template?

Save as template?